The industry might agree to savings in 2020 to bolster those negotiated in 2017, only to confront a new round of requests in 2022 or 2023. Any extension in 2020 will mean the industry just pays again for the 'certainty' it already has until mid-2022. …
The price of paying twice or three times for the same 'certainty'
September 14, 2020 CommentLatest News
Latest Video
New Stories
-
Older Australians given three weeks to have their say on in-home aged care services list
November 3, 2026 - - Latest News -
Diabetes scheme registrations fall as health department points to GLP-1 use
November 3, 2026 - - Latest News -
Report finds 196 missing medicines and billions in unreinvested PBS savings
November 3, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News -
Australians with thyroid eye disease gain first PBS subsidised treatment
November 2, 2026 - - Latest News -
‘We are now bridled only by our imagination’. Amgen’s Paul Burton on AI and medicine’s hinge moment
November 2, 2026 - - Latest News -
Edwards Lifesciences opens new Sydney head office as heart valve disease burden grows
November 1, 2026 - - Latest News